(5R,8S,9S,10R,13S,14S)-10,13-dimethyl-2,4,5,6,7,8,9,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthrene-3,17-dione

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 类固醇和类固醇衍生物
• 英文名称: (5R,8S,9S,10R,13S,14S)-10,13-dimethyl-2,4,5,6,7,8,9,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthrene-3,17-dione
• 化学式: C₁₉H₂₈O₂
• 分子量: 288.4
• InChiKey: RAJWOBJTTGJROA-YEOVLEPESA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  21
• 可旋转键数：
  0
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.89
• 拓扑面积：
  34.1
• 氢给体数：
  0
• 氢受体数：
  2

文献信息

• MEDICINAL APPLICATIONS OF BENZOIC ACID HYDRAZONES SYNTHESIZED ON THE BASIS OF STEROIDAL TIGOGENIN
  申请人：Shelar Ashok Ranganath

  公开号：US20110178317A1

  公开（公告）日：2011-07-21

  Novel benzoic acid hydrazones of 5α-androstan-3,17-dione have been prepared on the basis of steroidal tigogenin of the plant Yucca gloriosa . The hydrazones of the General Formula (I), General Formula (II) and General Formula (III) as shown in the accompanying FIGURE of the drawing are synthesized. The hydrazones have shown promising anti-T.B., anti-cancer and anti-HIV activity revealing immense potential as more efficacious, less toxic drugs with fewer undesirable side effects. They could also prove valuable in correcting hormonal abnormalities that cause severe health problems.

  5α-雄甾烷-3,17-二酮的新型苯甲酸肼已经根据植物优格龙胆甾原甙制备。根据图纸中显示的一般式(I)、一般式(II)和一般式(III)，合成了这些肼。这些肼显示出有希望的抗结核、抗癌和抗艾滋病活性，表明它们具有更有效、毒性更小、副作用更少的巨大潜力。它们还可能在纠正引起严重健康问题的激素异常方面具有价值。
• Hexahydrobenzo[f]quinolinones as 5-alpha-reductase inhibitors
  申请人：ELI LILLY AND COMPANY

  公开号：EP0531026A1

  公开（公告）日：1993-03-10

  The invention relates to 1,2,3,4,5,6-hexahydrobenzo[f]quinolin-3-ones, pharmaceutical formulations containing those compounds, and their use as steroid 5α-reductase inhibitors.

  本发明涉及 1,2,3,4,5,6-六氢苯并[f]喹啉-3-酮、含有这些化合物的药物制剂以及它们作为类固醇 5α 还原酶抑制剂的用途。
• Benzo f quinolinones as 5-alpha-reductase inhibitors
  申请人：ELI LILLY AND COMPANY

  公开号：EP0532190A2

  公开（公告）日：1993-03-17

  This invention relates to hexa- and octahydrobenzo[f]quinolin-3-ones, pharmaceutical formulations containing those compounds and methods of their use as steroid 5α reductase inhibitors.

  本发明涉及六氢和八氢苯并[f]喹啉-3-酮、含有这些化合物的药物制剂以及将其用作类固醇 5α 还原酶抑制剂的方法。
• Advanced drug development and manufacturing
  申请人：Los Alamos National Security, LLC

  公开号：EP2511844A2

  公开（公告）日：2012-10-17

  There is described an apparatus for measuring protein characteristics comprising an X-ray fluorescence (XRF) spectrometer comprising a source of polychromatic X-rays, an X-ray detector, a protein, a molecule that has been exposed to and at least weakly binds to the protein, a plurality of X-ray fluorescence signal data obtained by irradiating chemical elements in the protein and molecule with the polychromatic X-rays and a security system for maintaining records for the data from the plurality of X-ray fluorescence signal measurements. There is also described an x-ray microscope for measuring a sample.

  描述了一种测量蛋白质特性的仪器，该仪器包括一个 X 射线荧光 (XRF) 光谱仪，其中包括一个多色 X 射线源、一个 X 射线探测器、一个蛋白质、一个已暴露于该蛋白质并至少与该蛋白质弱结合的分子、通过用多色 X 射线照射蛋白质和分子中的化学元素而获得的多个 X 射线荧光信号数据，以及一个用于维护多个 X 射线荧光信号测量数据记录的安全系统。此外，还介绍了一种用于测量样品的 X 射线显微镜。
• 15β-substituted estrone derivatives as selective inhibitors of 17β-hydroxysteroid-dehydrogenases, method of preparation and use thereof
  申请人：USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V.V.I.

  公开号：US10759826B2

  公开（公告）日：2020-09-01

  15β-substituted derivatives of estrone of general formula I wherein R1, R2, R3, R4, R5 are independently selected from the group consisting of: C1-C4 alkyl, C1-C4 alkoxy, C1-C4 halogenalkyl, halogen, COOR6 wherein R6 is C1-C4 alkyl; H, OH; optionally, R3, R4 and R5 are each formed by a hydrogen atom, while R1 and R2 together form an aryl group, preferably naphthyl, in which the aromatic ring in position C-15 can be mono-, di-, tri-, tetra- and penta-substituted with substituents R1-R5. Compounds of the invention may be used for diagnosis and possibly also for the treatment of estrogen-dependent diseases.

  通式 I 的 15β-取代的雌酮衍生物 其中 R1、R2、R3、R4、R5 独立地选自由以下组成的组：C1-C4烷基、C1-C4烷氧基、C1-C4卤代烷基、卤素、COOR6（其中R6为C1-C4烷基）、H、OH；任选地，R3、R4和R5各自由一个氢原子构成，而R1和R2共同形成一个芳基，优选萘基，其中C-15位的芳环可以被取代基R1-R5单取代、二取代、三取代、四取代和五取代。本发明的化合物可用于诊断，也可用于治疗雌激素依赖性疾病。